Outcomes After Decompressive Surgery for Severe Cerebral Venous Sinus Thrombosis Associated or Not Associated with Vaccine-Induced Immune Thrombosis with Thrombocytopenia: A Multicenter Cohort Study
- PMID: 37498459
- PMCID: PMC10959787
- DOI: 10.1007/s12028-023-01782-6
Outcomes After Decompressive Surgery for Severe Cerebral Venous Sinus Thrombosis Associated or Not Associated with Vaccine-Induced Immune Thrombosis with Thrombocytopenia: A Multicenter Cohort Study
Erratum in
-
Correction: Outcomes After Decompressive Surgery for Severe Cerebral Venous Sinus Thrombosis Associated or Not Associated with Vaccine-Induced Immune Thrombosis with Thrombocytopenia: A Multicenter Cohort Study.Neurocrit Care. 2025 Oct;43(2):711-712. doi: 10.1007/s12028-025-02354-6. Neurocrit Care. 2025. PMID: 40825920 Free PMC article. No abstract available.
Abstract
Background: Clinical observations indicated that vaccine-induced immune thrombosis with thrombocytopenia (VITT)-associated cerebral venous sinus thrombosis (CVST) often has a space-occupying effect and thus necessitates decompressive surgery (DS). While comparing with non-VITT CVST, this study explored whether VITT-associated CVST exhibits a more fulminant clinical course, different perioperative and intensive care unit management, and worse long-term outcome.
Methods: This multicenter, retrospective cohort study collected patient data from 12 tertiary centers to address priorly formulated hypotheses concerning the clinical course, the perioperative management with related complications, extracerebral complications, and the functional outcome (modified Rankin Scale) in patients with VITT-associated and non-VITT CVST, both with DS.
Results: Both groups, each with 16 patients, were balanced regarding demographics, kind of clinical symptoms, and radiological findings at hospital admission. Severity of neurological symptoms, assessed with the National Institute of Health Stroke Scale, was similar between groups at admission and before surgery, whereas more patients with VITT-associated CVST showed a relevant midline shift (≥ 4 mm) before surgery (100% vs. 68.8%, p = 0.043). Patients with VITT-associated CVST tended to undergo DS early, i.e., ≤ 24 h after hospital admission (p = 0.077). Patients with VITT-associated CVST more frequently received platelet transfusion, tranexamic acid, and fibrinogen perioperatively. The postoperative management was comparable, and complications were evenly distributed. More patients with VITT-associated CVST achieved a favorable outcome (modified Rankin Scale ≤ 3) at 3 months (p = 0.043).
Conclusions: Although the prediction of individual courses remains challenging, DS should be considered early in VITT-associated CVST because an overall favorable outcome appears achievable in these patients.
Keywords: COVID-19; Cerebral venous sinus thrombosis; Decompressive surgery; Space-occupying infarction; VITT; Vaccination; Vaccine-induced immune thrombosis with thrombocytopenia.
© 2023. The Author(s).
Conflict of interest statement
FS reports personal fees from Bristol-Myers Squibb as well as MD Horizonte and AMEOS, both outside the submitted work. MW received speakers onoria and consulting fees from Alexion Pharma GmbH (formerly Portola). AG reports personal fees from Bristol-Myers Squibb, Boehringer-Ingelheim, Pfizer, Daichii Sankyo, Ipsen Pharma and Merz. JOP, MK, AA, NE, WDN, JL, EG, JW, TL, RD, MW, HS, AB, MC, AM, SP, DB, DL, CP, CR, and DM declare that there is no conflict of interest related to the presented work.
References
-
- Coutinho JM, Zuurbier SM, Aramideh M, Stam J. The incidence of cerebral venous thrombosis: a cross-sectional study. Stroke. 2012;43:3375–7. 10.1161/STROKEAHA.112.671453. - PubMed
-
- Jacob J, Klamroth R, Ploner T, Harder T, Koch J, Wichmann O, et al., Incidence of cerebral venous sinus thrombosis in adults in Germany—a retrospective study using health claims data. 2021. https://www.researchsquare.com/article/rs-428469/v2. 10.21203/rs.3.rs-428469/v2.
-
- Ferro JM, Bousser MG, Canhão P, Coutinho JM, Crassard I, Dentali F, et al. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis: endorsed by the European Academy of Neurology. Eur J Neurol. 2017;24:1203–13. 10.1111/ene.13381. - PubMed
-
- Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F, ISCVT Investigators. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004;35:664–70. 10.1161/01.STR.0000117571.76197.26. - PubMed
-
- Triquenot Bagan A, Crassard I, Drouet L, Barbieux-Guillot M, Marlu R, Robinet-Borgomino E, et al. Cerebral venous thrombosis: clinical, radiological, biological, and etiological characteristics of a French prospective cohort (FPCCVT)—comparison With ISCVT cohort. Front Neurol. 2021;12:753110. 10.3389/fneur.2021.753110. - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical